Cargando…
The prevalence of people who inject drugs among those with HIV late presentation: a meta-analysis
BACKGROUND: One of the most important routes of HIV transmission is through injections of drugs, and this group, due to unawareness of their infection, causes the spread of HIV. The coexistence of other opportunistic infections and diseases with HIV among people who inject drugs (PWID) imposes healt...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8832672/ https://www.ncbi.nlm.nih.gov/pubmed/35144631 http://dx.doi.org/10.1186/s13011-022-00439-5 |
_version_ | 1784648772394942464 |
---|---|
author | Farhadian, Negin Karami Matin, Behzad Farnia, Vahid Zamanian, Mohammad Hossein Najafi, Farid Farhadian, Maryam |
author_facet | Farhadian, Negin Karami Matin, Behzad Farnia, Vahid Zamanian, Mohammad Hossein Najafi, Farid Farhadian, Maryam |
author_sort | Farhadian, Negin |
collection | PubMed |
description | BACKGROUND: One of the most important routes of HIV transmission is through injections of drugs, and this group, due to unawareness of their infection, causes the spread of HIV. The coexistence of other opportunistic infections and diseases with HIV among people who inject drugs (PWID) imposes healthcare costs and is associated with high morbidity/mortality rates. Early detection of HIV among PWID is essential to prevent and control the spread of the disease. OBJECTIVES: This study aimed to determine the prevalence of PWID among those with late presentation (LP). METHODS: Three electronic databases of PubMed, Scopus, and Web of science were searched using appropriate keywords. Besides the prevalence data reported for PWID among LP, the other outcomes of interest were LP defined as having CD4 count < 350 cells/μL or HIV or advanced disease defined with CD4 count < 200 cells/μL or HIV at the time of diagnosis. RESULTS: Of the 160 studies found, only eight met the inclusion criteria. Among those presented late, 36.5% were PWID (95% CI = 24.88–48.17). Compared with men who have sex with men (MSM), HIV-infected PWID had a higher risk of LP [OR = 1.51; 95% CI = 0.96–2.06]. CONCLUSION: The results of this study show that HIV is diagnosed late in the majority of PWID when CD4 is less than 350 cells/μL. Targeted interventions/strategies are highly required to reduce LP among HIV-infected PWID. |
format | Online Article Text |
id | pubmed-8832672 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-88326722022-02-11 The prevalence of people who inject drugs among those with HIV late presentation: a meta-analysis Farhadian, Negin Karami Matin, Behzad Farnia, Vahid Zamanian, Mohammad Hossein Najafi, Farid Farhadian, Maryam Subst Abuse Treat Prev Policy Research BACKGROUND: One of the most important routes of HIV transmission is through injections of drugs, and this group, due to unawareness of their infection, causes the spread of HIV. The coexistence of other opportunistic infections and diseases with HIV among people who inject drugs (PWID) imposes healthcare costs and is associated with high morbidity/mortality rates. Early detection of HIV among PWID is essential to prevent and control the spread of the disease. OBJECTIVES: This study aimed to determine the prevalence of PWID among those with late presentation (LP). METHODS: Three electronic databases of PubMed, Scopus, and Web of science were searched using appropriate keywords. Besides the prevalence data reported for PWID among LP, the other outcomes of interest were LP defined as having CD4 count < 350 cells/μL or HIV or advanced disease defined with CD4 count < 200 cells/μL or HIV at the time of diagnosis. RESULTS: Of the 160 studies found, only eight met the inclusion criteria. Among those presented late, 36.5% were PWID (95% CI = 24.88–48.17). Compared with men who have sex with men (MSM), HIV-infected PWID had a higher risk of LP [OR = 1.51; 95% CI = 0.96–2.06]. CONCLUSION: The results of this study show that HIV is diagnosed late in the majority of PWID when CD4 is less than 350 cells/μL. Targeted interventions/strategies are highly required to reduce LP among HIV-infected PWID. BioMed Central 2022-02-10 /pmc/articles/PMC8832672/ /pubmed/35144631 http://dx.doi.org/10.1186/s13011-022-00439-5 Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data. |
spellingShingle | Research Farhadian, Negin Karami Matin, Behzad Farnia, Vahid Zamanian, Mohammad Hossein Najafi, Farid Farhadian, Maryam The prevalence of people who inject drugs among those with HIV late presentation: a meta-analysis |
title | The prevalence of people who inject drugs among those with HIV late presentation: a meta-analysis |
title_full | The prevalence of people who inject drugs among those with HIV late presentation: a meta-analysis |
title_fullStr | The prevalence of people who inject drugs among those with HIV late presentation: a meta-analysis |
title_full_unstemmed | The prevalence of people who inject drugs among those with HIV late presentation: a meta-analysis |
title_short | The prevalence of people who inject drugs among those with HIV late presentation: a meta-analysis |
title_sort | prevalence of people who inject drugs among those with hiv late presentation: a meta-analysis |
topic | Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8832672/ https://www.ncbi.nlm.nih.gov/pubmed/35144631 http://dx.doi.org/10.1186/s13011-022-00439-5 |
work_keys_str_mv | AT farhadiannegin theprevalenceofpeoplewhoinjectdrugsamongthosewithhivlatepresentationametaanalysis AT karamimatinbehzad theprevalenceofpeoplewhoinjectdrugsamongthosewithhivlatepresentationametaanalysis AT farniavahid theprevalenceofpeoplewhoinjectdrugsamongthosewithhivlatepresentationametaanalysis AT zamanianmohammadhossein theprevalenceofpeoplewhoinjectdrugsamongthosewithhivlatepresentationametaanalysis AT najafifarid theprevalenceofpeoplewhoinjectdrugsamongthosewithhivlatepresentationametaanalysis AT farhadianmaryam theprevalenceofpeoplewhoinjectdrugsamongthosewithhivlatepresentationametaanalysis AT farhadiannegin prevalenceofpeoplewhoinjectdrugsamongthosewithhivlatepresentationametaanalysis AT karamimatinbehzad prevalenceofpeoplewhoinjectdrugsamongthosewithhivlatepresentationametaanalysis AT farniavahid prevalenceofpeoplewhoinjectdrugsamongthosewithhivlatepresentationametaanalysis AT zamanianmohammadhossein prevalenceofpeoplewhoinjectdrugsamongthosewithhivlatepresentationametaanalysis AT najafifarid prevalenceofpeoplewhoinjectdrugsamongthosewithhivlatepresentationametaanalysis AT farhadianmaryam prevalenceofpeoplewhoinjectdrugsamongthosewithhivlatepresentationametaanalysis |